Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

Researchers found that biopsies from patients who had not undergone any treatment provided insight into H3K27-altered diffuse intrinsic pontine glioma. Utilizing CBTN data to verify their results, researchers explore molecular alterations and biomarkers for this tumor type.

Previous PostRetrospective Dataset And Survey Analyses Identify Gaps In Data Collection For Craniopharyngioma And Priorities Of Patients And Families Affected By The Disease
Next PostProteogenomic Discovery of Neoantigens Facilitates Personalized Multi-antigen Targeted T Cell Immunotherapy for Brain Tumors

Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

Previous PostRetrospective Dataset And Survey Analyses Identify Gaps In Data Collection For Craniopharyngioma And Priorities Of Patients And Families Affected By The Disease

Next PostProteogenomic Discovery of Neoantigens Facilitates Personalized Multi-antigen Targeted T Cell Immunotherapy for Brain Tumors

Get the Latest

Stay Informed